Improving medication adherence beats resistance testing for better HIV outcomes in African youth

FHS
July 18, 2024
11:10 pm

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa.

Risk adjusted net present value: What is the current valuation of Bavarian Nordic’s PXVX-0317?

PXVX-0317 is a subunit vaccine commercialized by Bavarian Nordic, with a leading Phase III program in Chikungunya Fever.

November 20, 2023

International report paves way for precision diabetes medicine breakthrough

Precision medicine for prevention, diagnosis, treatment, and prognosis for Diabetes.

October 9, 2023

Researchers show how communication networks in the tumor microenvironment promote cancer growth

Tumors consist of both the actual, malignant cancer cells and healthy, non-transformed cells in the immediate environment.

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.